Oxidopamine

Oxidopamine (also known as 6-hydroxydopamine, 6-OHDA, or 6-hydroxyDA) is a neurotoxic compound primarily used in scientific research to selectively destroy dopaminergic and noradrenergic neurons. It is often employed in the creation of animal models for Parkinson's disease, as it mimics the dopamine neuron degeneration that characterizes this condition. The mechanism of action of oxidopamine involves its uptake into the neurons via the norepinephrine transporter and the dopamine transporter, where it then undergoes auto-oxidation leading to the generation of reactive oxygen species (ROS) and subsequent neuronal death.

Mechanism of Action

Oxidopamine's neurotoxicity is primarily attributed to its structural similarity to the neurotransmitters dopamine and norepinephrine, which allows it to be taken up by the same transporters. Once inside the neuron, oxidopamine undergoes auto-oxidation, a process that generates highly reactive free radicals. These free radicals cause oxidative stress by damaging cellular components such as lipids, proteins, and DNA. Additionally, oxidopamine can inhibit mitochondrial complex I, leading to further production of reactive oxygen species and disruption of cellular energy metabolism. The combination of these effects results in the selective death of dopaminergic and noradrenergic neurons.

Uses in Research

Oxidopamine is widely used in neuroscience research to study the pathophysiology of neurodegenerative diseases, especially Parkinson's disease. By creating animal models that mimic the selective loss of dopaminergic neurons seen in Parkinson's, researchers can investigate the disease's progression, identify potential therapeutic targets, and evaluate the efficacy of new treatments. Furthermore, studies involving oxidopamine have contributed to a better understanding of the role of oxidative stress in neurodegeneration.

Safety and Handling

Due to its neurotoxic properties, handling oxidopamine requires caution. Researchers must employ appropriate safety measures, including the use of personal protective equipment (PPE) and working within a chemical fume hood. Disposal of oxidopamine and materials contaminated with it must follow specific protocols to prevent environmental contamination and exposure.

See Also

• Parkinson's disease
• Neurodegeneration
• Dopamine
• Norepinephrine
• Reactive oxygen species
• Mitochondrial complex I

References

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian